148 related articles for article (PubMed ID: 30318087)
1. HER1-based vaccine: Simultaneous activation of humoral and cellular immune response.
Bergado Báez G; Hernández Fernández DR; Mazorra Herrera Z; Sánchez Ramírez B
Semin Oncol; 2018 Jan; 45(1-2):75-83. PubMed ID: 30318087
[TBL] [Abstract][Full Text] [Related]
2. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.
Sánchez Ramírez J; Morera Díaz Y; Bequet-Romero M; Hernández-Bernal F; Selman-Housein Bernal KH; de la Torre Santos A; Santiesteban Álvarez ER; Martín Bauta Y; Bermúdez Badell CH; de la Torre Pupo J; Gavilondo JV; ; Ayala Avila M
BMC Immunol; 2017 Jul; 18(1):39. PubMed ID: 28747172
[TBL] [Abstract][Full Text] [Related]
4. Non-clinical immuno-toxicological evaluation of HER1 cancer vaccine in non-human primates: a 12-month study.
Barro AM; Rivero AI; Goñi AL; Navarro BO; Angarica MM; Ramírez BS; Bedoya DM; Triana CG; Rodríguez AM; Parada ÁC
Vaccine; 2012 Dec; 31(1):89-95. PubMed ID: 23142132
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
6. Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine.
Morera Y; Sánchez J; Bequet-Romero M; Selman-Housein KH; de la Torre A; Hernández-Bernal F; Martín Y; Garabito A; Piñero J; Bermúdez C; de la Torre J; Ayala M; Gavilondo JV
Vaccine; 2017 Jun; 35(28):3582-3590. PubMed ID: 28536029
[TBL] [Abstract][Full Text] [Related]
7. Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.
Sánchez Ramírez J; Morera Díaz Y; Bequet-Romero M; Hernández-Bernal F; Martín Bauta Y; Selman-Housein Bernal KH; de la Torre Santos AV; Pérez de la Iglesia M; Trimiño Lorenzo L; ; Ayala Avila M
BMC Immunol; 2020 Mar; 21(1):12. PubMed ID: 32171254
[TBL] [Abstract][Full Text] [Related]
8. CIMAvax-EGF: Toward long-term survival of advanced NSCLC.
Saavedra D; Neninger E; Rodriguez C; Viada C; Mazorra Z; Lage A; Crombet T
Semin Oncol; 2018 Jan; 45(1-2):34-40. PubMed ID: 30318082
[TBL] [Abstract][Full Text] [Related]
9. Immuno-toxicological evaluation of her1 cancer vaccine in non-human primates: a 6-month subcutaneous study.
Mancebo Rodríguez A; Bergado Báez G; Acosta Lago E; León Goñi A; Blanco Gámez D; Fuentes Morales D; Hernández Fernández DR; Sánchez Ramírez B; Pérez Barreda A; Casacó Parada Á
Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):283-290. PubMed ID: 33722157
[No Abstract] [Full Text] [Related]
10. Xenogeneic cell-based vaccine therapy for colorectal cancer: Safety, association of clinical effects with vaccine-induced immune responses.
Seledtsova GV; Shishkov AA; Kaschenko EA; Seledtsov VI
Biomed Pharmacother; 2016 Oct; 83():1247-1252. PubMed ID: 27565847
[TBL] [Abstract][Full Text] [Related]
11. Specific active immunotherapy with the HEBERSaVax VEGF-based cancer vaccine: From bench to bedside.
Morera-Díaz Y; Gavilondo JV; Bequet-Romero M; Sánchez Ramírez J; Hernández-Bernal F; Selman-Housein KH; Perez L; Ayala-Ávila M
Semin Oncol; 2018 Jan; 45(1-2):68-74. PubMed ID: 30318086
[TBL] [Abstract][Full Text] [Related]
12. Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?
Lutz ER; Jaffee EM
Cancer Immunol Res; 2014 Jun; 2(6):518-21. PubMed ID: 24795140
[No Abstract] [Full Text] [Related]
13. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
14. Strategies in cancer vaccines development.
Cunto-Amesty G; Monzavi-Karbassi B; Luo P; Jousheghany F; Kieber-Emmons T
Int J Parasitol; 2003 May; 33(5-6):597-613. PubMed ID: 12782058
[TBL] [Abstract][Full Text] [Related]
15. Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant.
Ramírez BS; Pestana ES; Hidalgo GG; García TH; Rodríguez RP; Ullrich A; Férnandez LE
Int J Cancer; 2006 Nov; 119(9):2190-9. PubMed ID: 16841332
[TBL] [Abstract][Full Text] [Related]
16. Vaccines and melanoma.
Ott PA; Fritsch EF; Wu CJ; Dranoff G
Hematol Oncol Clin North Am; 2014 Jun; 28(3):559-69. PubMed ID: 24880947
[TBL] [Abstract][Full Text] [Related]
17. Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.
Obeid J; Hu Y; Slingluff CL
Semin Oncol; 2015 Aug; 42(4):549-61. PubMed ID: 26320060
[TBL] [Abstract][Full Text] [Related]
18. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
[TBL] [Abstract][Full Text] [Related]
19. Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer.
Aguilar FF; Barranco JJ; Fuentes EB; Aguilera LC; Sáez YL; Santana MD; Vázquez EP; Baker RB; Acosta OR; Pérez HG; Nieto GG
Vaccine; 2012 Oct; 30(46):6595-9. PubMed ID: 22921738
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
